When President Donald Trump launched his bold trade policy agenda back in 2018, targeting China with sweeping tariffs, pharmaceuticals were conspicuously spared, unlike semiconductors, lumber, and copper, that were caught in the economic crossfire
News and analysis on drug development, clinical evidence, regulatory approvals, pharmacology, and the science behind treatments — from small molecules to biologics.
